FindTrial
Sign In

Exogenous progesterone as ovulation trigger – a pilot study

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523850-15-00
Enrollment
10
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Number of mature oocytes (MII) following progesterone-induced oocyte maturation.

Detailed description

Endocrinological profile (E2, P4, LH and FSH) 12h after trigger, Endocrinological profile (E2, P4, LH and FSH) on the morning of egg retrieval

Interventions

DRUGCyclogest 400 mg óvulos

Sponsors

Instituto Valenciano De Infertilidade Clinica De Reproducao Assistida Lda.
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Number of mature oocytes (MII) following progesterone-induced oocyte maturation.—

Secondary

MeasureTime frame
Endocrinological profile (E2, P4, LH and FSH) 12h after trigger, Endocrinological profile (E2, P4, LH and FSH) on the morning of egg retrieval—

Outcome results

None listed

Source: EU CTIS · Data processed: May 23, 2026